Edwards Lifesciences Corp financial data

Symbol
EW on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
One Edwards Way, Irvine, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CVG CONTROLLED INC (to 1/21/2000)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 356 % +13.8%
Quick Ratio 77.6 % -8.21%
Debt-to-equity 36.3 % -12.4%
Return On Equity 53.6 %
Return On Assets 39.5 %
Operating Margin 25.6 % -6.64%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 590M shares -2.75%
Common Stock, Shares, Outstanding 590M shares -2.75%
Entity Public Float 56.8B USD -2.74%
Common Stock, Value, Issued 654M USD +0.68%
Weighted Average Number of Shares Outstanding, Basic 597M shares -1.61%
Weighted Average Number of Shares Outstanding, Diluted 598M shares -1.87%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.34B USD +18.7%
Research and Development Expense 1.14B USD +15.9%
Operating Income (Loss) 1.62B USD +10.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.74B USD +14.1%
Income Tax Expense (Benefit) 186M USD -3.27%
Net Income (Loss) Attributable to Parent 4.16B USD +698%
Earnings Per Share, Basic 6.94 USD/shares +194%
Earnings Per Share, Diluted 6.93 USD/shares +196%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.68B USD +161%
Accounts Receivable, after Allowance for Credit Loss, Current 716M USD -3.22%
Inventory, Net 1.1B USD +6.96%
Other Assets, Current 231M USD -2.04%
Assets, Current 6.73B USD +65.4%
Deferred Income Tax Assets, Net 888M USD +36.3%
Property, Plant and Equipment, Net 1.68B USD -0.33%
Operating Lease, Right-of-Use Asset 104M USD +14.9%
Intangible Assets, Net (Excluding Goodwill) 956M USD +122%
Goodwill 1.61B USD +23.7%
Other Assets, Noncurrent 684M USD +52.8%
Assets 13B USD +38.4%
Accounts Payable, Current 173M USD -9.34%
Employee-related Liabilities, Current 312M USD -8.21%
Liabilities, Current 1.94B USD +56.9%
Operating Lease, Liability, Noncurrent 85M USD +21.4%
Other Liabilities, Noncurrent 323M USD +34.2%
Liabilities 3.36B USD +27.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -253M USD -0.96%
Retained Earnings (Accumulated Deficit) 12.8B USD +48.2%
Stockholders' Equity Attributable to Parent 9.55B USD +43.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 9.61B USD +42.9%
Liabilities and Equity 13B USD +38.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.5M USD -117%
Net Cash Provided by (Used in) Financing Activities 61.7M USD
Net Cash Provided by (Used in) Investing Activities 63.1M USD +12520%
Common Stock, Shares Authorized 1.05B shares 0%
Common Stock, Shares, Issued 654M shares +0.68%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 81M USD -22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.68B USD +161%
Deferred Tax Assets, Valuation Allowance 90.2M USD -8.98%
Deferred Tax Assets, Gross 958M USD +37.6%
Operating Lease, Liability 97.9M USD +3.05%
Payments to Acquire Property, Plant, and Equipment 65.3M USD +6.18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.16B USD +189%
Lessee, Operating Lease, Liability, to be Paid 106M USD +3.02%
Property, Plant and Equipment, Gross 2.61B USD +9.38%
Operating Lease, Liability, Current 24.2M USD -0.41%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.6M USD +5.95%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.8M USD -0.74%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.9M USD +2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.3M USD +30.4%
Deferred Tax Assets, Operating Loss Carryforwards 75.9M USD +5.86%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 657M USD +20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.9M USD +22.9%
Operating Lease, Payments 8.2M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 38.5M USD +9.38%
Share-based Payment Arrangement, Expense 155M USD +19.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%